Key indicators: single-crystal X-ray study; T = 296 K; mean (C-C) = 0.003 Å; R factor = 0.036; wR factor = 0.089; data-to-parameter ratio = 19.1.
The asymmetric unit of the title compound, C 11 H 17 ClNO + Á-0.5C 2 O 4 2À , consists of one N-[2-(2-chlorophenyl)-2-hydroxyethyl]propan-2-ammonium cation and one-half of a centrosymmetric oxalate anion. In the cation, the C/C/N plane of the ethylammonium group is almost perpendicular to the benzene ring, with a dihedral angle of 88.72 (17) . In the crystal structure, the two components are connected by O-HÁ Á ÁO and N-HÁ Á ÁO hydrogen bonds, forming a supramolecular tape along the a axis. Between the tapes, a C-HÁ Á ÁO interaction is observed.
Related literature
For related structures, see : Czugler et al. (2007) ; Marsau et al. (1979) ; Martin & Pinkerton (1998) ; Tang et al. (2009) .
Experimental
Crystal data Table 1 Hydrogen-bond geometry (Å , ). 
Comment
Many crystalline compounds of oxalic acid has been studied previously (Marsau et al., 1979; Martin & Pinkerton, 1998; Czugler et al., 2007) . To test the capability of oxalic acid we have synthesized the title compound, (I), containing oxalic acid and clorprenaline (Tang et al., 2009) which is one of a series of structurally related β-adrenoceptorblocking drugs.
Association of one clorprenaline and half of oxalic acid acid molecule leads to the title compound ( supplementary materials sup-6 Fig. 1 
Hydrogen-bond geometry (Å, °)

